Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate. 1994

K Niwa, and Y Yokoyama, and T Tanaka, and T Murase, and S Morishita, and M Itoh, and N Itoh, and K Shimokawa, and T Tamaya
Department of Obstetrics and Gynecology, Gifu University School of Medicine, Japan.

A 32-year infertile Japanese woman suffered from endometrial cancer, which was treated with repeated endometrial curettage and medroxyprogesterone acetate for 6 months. The patient then became pregnant and was delivered of a live-born male infant at 37 weeks gestation by cesarean section for placenta previa. At cesarean section there were no abnormal findings in the uterine cavity or other pelvic organs.

UI MeSH Term Description Entries
D010923 Placenta Previa Abnormal placentation in which the PLACENTA implants in the lower segment of the UTERUS (the zone of dilation) and may cover part or all of the opening of the CERVIX. It is often associated with serious antepartum bleeding and PREMATURE LABOR. Placenta Praevia
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D002585 Cesarean Section Extraction of the FETUS by means of abdominal HYSTEROTOMY. Abdominal Delivery,Delivery, Abdominal,C-Section (OB),Caesarean Section,Postcesarean Section,Abdominal Deliveries,C Section (OB),C-Sections (OB),Caesarean Sections,Cesarean Sections,Deliveries, Abdominal
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004107 Dilatation and Curettage Dilatation of the cervix uteri followed by a scraping of the endometrium with a curette. Curettage and Dilatation,Dilatation & Curettage
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Niwa, and Y Yokoyama, and T Tanaka, and T Murase, and S Morishita, and M Itoh, and N Itoh, and K Shimokawa, and T Tamaya
October 2000, Gynecologic oncology,
K Niwa, and Y Yokoyama, and T Tanaka, and T Murase, and S Morishita, and M Itoh, and N Itoh, and K Shimokawa, and T Tamaya
January 1990, Gynakologische Rundschau,
K Niwa, and Y Yokoyama, and T Tanaka, and T Murase, and S Morishita, and M Itoh, and N Itoh, and K Shimokawa, and T Tamaya
July 1985, Gynecologic oncology,
K Niwa, and Y Yokoyama, and T Tanaka, and T Murase, and S Morishita, and M Itoh, and N Itoh, and K Shimokawa, and T Tamaya
May 2012, Oncology letters,
K Niwa, and Y Yokoyama, and T Tanaka, and T Murase, and S Morishita, and M Itoh, and N Itoh, and K Shimokawa, and T Tamaya
January 1979, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
K Niwa, and Y Yokoyama, and T Tanaka, and T Murase, and S Morishita, and M Itoh, and N Itoh, and K Shimokawa, and T Tamaya
June 1994, British journal of obstetrics and gynaecology,
K Niwa, and Y Yokoyama, and T Tanaka, and T Murase, and S Morishita, and M Itoh, and N Itoh, and K Shimokawa, and T Tamaya
February 1986, Obstetrics and gynecology,
K Niwa, and Y Yokoyama, and T Tanaka, and T Murase, and S Morishita, and M Itoh, and N Itoh, and K Shimokawa, and T Tamaya
July 1987, Nihon Sanka Fujinka Gakkai zasshi,
K Niwa, and Y Yokoyama, and T Tanaka, and T Murase, and S Morishita, and M Itoh, and N Itoh, and K Shimokawa, and T Tamaya
May 1989, Zhonghua fu chan ke za zhi,
K Niwa, and Y Yokoyama, and T Tanaka, and T Murase, and S Morishita, and M Itoh, and N Itoh, and K Shimokawa, and T Tamaya
January 1982, Acta obstetricia et gynecologica Scandinavica,
Copied contents to your clipboard!